ATTR Amyloidosis Treatment Market is driven by rising market demand
The ATTR Amyloidosis Treatment Market encompasses therapies designed to address transthyretin (ATTR) amyloidosis, a progressive disorder characterized by abnormal protein deposits in organs and tissues. Core products include RNA interference (RNAi) therapies, monoclonal antibodies, and small-molecule stabilizers that prevent transthyretin misfolding. Advantages of these treatments lie in...
0 Comments 0 Shares 50 Views 0 Reviews